About this FactMed analysis covering adverse side effect reports of AIRBORNE patients who developed APHASIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking AIRBORNE reported APHASIA to the FDA. A total of 20 AIRBORNE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AIRBORNE and APHASIA. In doing so, we compare AIRBORNE with other drugs that cause APHASIA, to help you evaluate whether or not AIRBORNE causes APHASIA. Likewise, this page shows the most highly-reported side effects of AIRBORNE, so you can see if APHASIA ranks among AIRBORNE's most well-known side effects.
Summary Statistics
Reports of AIRBORNE causing APHASIA: 1
Reports of any side effect of AIRBORNE : 20
Percentage of AIRBORNE patients where APHASIA is a reported side effect: 5.0000%

FDA reports of any drug causing APHASIA : 9964
Average percentage for all medicated patients where APHASIA is reported as a complication: 0.0624%

Physician opinion on AIRBORNE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AIRBORNE:
MEDICAL DIET ( 3 patients )
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 1 patients )
NASOPHARYNGITIS ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with APHASIA:

ASPIRIN (872 patients)
TYSABRI (748 patients)
AVONEX (567 patients)
SEROQUEL (382 patients)
LYRICA (361 patients)
VIOXX (359 patients)
HEPARIN SODIUM INJECTION (355 patients)
LIPITOR (323 patients)
METHOTREXATE (297 patients)
NEURONTIN (290 patients)
PLAVIX (283 patients)
TOPAMAX (246 patients)
LASIX (245 patients)
KEPPRA (241 patients)
PREDNISONE (240 patients)
LISINOPRIL (238 patients)
SYNTHROID (235 patients)
CYMBALTA (234 patients)
HUMIRA (234 patients)
NEXIUM (234 patients)
XANAX (228 patients)
COUMADIN (224 patients)
OMEPRAZOLE (219 patients)
LANTUS (218 patients)
FORTEO (215 patients)
SIMVASTATIN (214 patients)
LEXAPRO (213 patients)
ATENOLOL (205 patients)
ZOLOFT (202 patients)
FUROSEMIDE (201 patients)
HYDROCHLOROTHIAZIDE (198 patients)
LEVOTHYROXINE SODIUM (196 patients)
CLONAZEPAM (194 patients)
YASMIN (190 patients)
LAMICTAL (186 patients)
DEXAMETHASONE (186 patients)
IBUPROFEN (184 patients)
YAZ (184 patients)
REMICADE (184 patients)
DIGOXIN (176 patients)
FOLIC ACID (175 patients)
FOSAMAX (174 patients)
DIAZEPAM (171 patients)
ACETAMINOPHEN (169 patients)
LORAZEPAM (166 patients)
DIOVAN (163 patients)
GABAPENTIN (163 patients)
ZOCOR (162 patients)
PAXIL (161 patients)
WELLBUTRIN (161 patients)
METFORMIN HCL (160 patients)
NEXAVAR (154 patients)
ALBUTEROL (153 patients)
ZOMETA (153 patients)
ADVAIR DISKUS 100/50 (153 patients)
VICODIN (151 patients)
POTASSIUM CHLORIDE (151 patients)
ZYPREXA (150 patients)
BACLOFEN (149 patients)
EFFEXOR (146 patients)
HEPARIN SODIUM (145 patients)
EFFEXOR XR (144 patients)
ATIVAN (141 patients)
CELEBREX (138 patients)
NORVASC (136 patients)
VITAMIN D (136 patients)
DURAGESIC-100 (134 patients)
PREVACID (133 patients)
REBIF (131 patients)
PAROXETINE HCL (130 patients)
AMBIEN (129 patients)
RISPERDAL (126 patients)
TOPIRAMATE (126 patients)
WARFARIN SODIUM (126 patients)
TEGRETOL (125 patients)
AVASTIN (124 patients)
TRAMADOL HCL (121 patients)
CITALOPRAM HYDROBROMIDE (120 patients)
TOPROL-XL (119 patients)
CYCLOPHOSPHAMIDE (119 patients)
LEVAQUIN (117 patients)
TRAZODONE HCL (117 patients)
LAMOTRIGINE (117 patients)
ALPRAZOLAM (117 patients)
PREDNISONE TAB (116 patients)
PROTONIX (116 patients)
ENBREL (115 patients)
KLONOPIN (114 patients)
PREDNISOLONE (113 patients)
OXYCODONE HCL (112 patients)
CRESTOR (111 patients)
PRILOSEC (111 patients)
CALCIUM (110 patients)
ACYCLOVIR (110 patients)
CHANTIX (109 patients)
DILANTIN (109 patients)
FENTANYL (109 patients)
CELEXA (108 patients)
AVELOX (108 patients)
MULTI-VITAMIN (107 patients)
SINGULAIR (106 patients)
OXYCONTIN (106 patients)
ZOFRAN (102 patients)
MIRTAZAPINE (100 patients)
METOPROLOL TARTRATE (100 patients)
RAMIPRIL (100 patients)
VALTREX (100 patients)
DEPAKOTE (99 patients)
PRADAXA (99 patients)
EXELON (98 patients)
AMLODIPINE (98 patients)
HUMALOG (95 patients)
INSULIN (95 patients)
AREDIA (95 patients)
CISPLATIN (94 patients)
NEORAL (93 patients)
CARBAMAZEPINE (92 patients)
AMITRIPTYLINE HCL (92 patients)
PERCOCET (92 patients)
NITROGLYCERIN (91 patients)
PHENYTOIN (90 patients)
PROZAC (90 patients)
HEPARIN (90 patients)
VALIUM (85 patients)
VALPROATE SODIUM (84 patients)
AMOXICILLIN (83 patients)
DILAUDID (83 patients)
LOVENOX (83 patients)
NAMENDA (82 patients)
AVANDIA (82 patients)
PREMARIN (82 patients)
LEVETIRACETAM (81 patients)
ALLOPURINOL (79 patients)
ARICEPT (79 patients)
PROMETHAZINE (77 patients)
MOTRIN (77 patients)
METOCLOPRAMIDE (77 patients)
MORPHINE (76 patients)
DEPAKENE (75 patients)
ABILIFY (74 patients)
FLUOROURACIL (74 patients)
GILENYA (73 patients)
GABITRIL (73 patients)
SEROQUEL XR (73 patients)
LITHIUM CARBONATE (73 patients)
BENADRYL (72 patients)
DECADRON (72 patients)
CLONIDINE (71 patients)
HALDOL (70 patients)
MULTI-VITAMINS (70 patients)
FLUOXETINE (68 patients)
CIPROFLOXACIN (67 patients)
ZYRTEC (67 patients)
REVLIMID (67 patients)
TYLENOL (CAPLET) (67 patients)
SPIRIVA (66 patients)
CALCIUM CARBONATE (66 patients)
BACTRIM (66 patients)
PROVIGIL (66 patients)
TRILEPTAL (65 patients)
CYTARABINE (65 patients)
BEVACIZUMAB (64 patients)
TACROLIMUS (64 patients)
COPAXONE (64 patients)
CLOZAPINE (63 patients)
TEMAZEPAM (63 patients)
ZANTAC (63 patients)
ACTONEL (63 patients)
CIPRO (62 patients)
PANTOPRAZOLE (62 patients)
METHYLPREDNISOLONE (62 patients)
GLEEVEC (61 patients)
LANSOPRAZOLE (61 patients)
METOPROLOL (61 patients)
GLUCOPHAGE (61 patients)
ALLEGRA (60 patients)
ACETYLSALICYLIC ACID SRT (60 patients)
DOXYCYCLINE (60 patients)
NUVARING (59 patients)
ENALAPRIL MALEATE (59 patients)
COREG (59 patients)
ALDACTONE (59 patients)
CYCLOSPORINE (59 patients)
TYLENOL (59 patients)
RISPERIDONE (58 patients)
CARBOPLATIN (58 patients)
ETOPOSIDE (57 patients)
OLANZAPINE (57 patients)
LEVOXYL (57 patients)
FERROUS SULFATE TAB (57 patients)
REGLAN (57 patients)
VITAMINS (56 patients)
FLUCONAZOLE (56 patients)
LOPRESSOR (56 patients)
LORTAB (55 patients)
AUGMENTIN '125' (54 patients)
METFORMIN (54 patients)
GLYBURIDE (54 patients)
POTASSIUM (53 patients)
CARVEDILOL (53 patients)
METOPROLOL SUCCINATE (53 patients)
ATORVASTATIN CALCIUM (53 patients)
NYSTATIN (53 patients)
SOLU-MEDROL (52 patients)
BETASERON (52 patients)
DIOVAN HCT (51 patients)
RANITIDINE (51 patients)
VINCRISTINE (51 patients)
MORPHINE SULFATE (51 patients)
CLOPIDOGREL (51 patients)
Most common side effects for patients taking AIRBORNE:
ALOPECIA (4 patients)
CONFUSIONAL STATE (4 patients)
AGEUSIA (3 patients)
ARTHRALGIA (3 patients)
LIGAMENT OPERATION (3 patients)
INFLUENZA (3 patients)
DRUG EFFECT DECREASED (3 patients)
ACTIVITIES OF DAILY LIVING IMPAIRED (2 patients)
VISION BLURRED (2 patients)
RESTLESSNESS (2 patients)
NASOPHARYNGITIS (2 patients)
MULTIPLE MYELOMA (2 patients)
CEREBROVASCULAR ACCIDENT (2 patients)
COORDINATION ABNORMAL (2 patients)
DRUG INEFFECTIVE (2 patients)
HYPOAESTHESIA (2 patients)
EPISTAXIS (2 patients)
DYSGRAPHIA (2 patients)
DYSARTHRIA (2 patients)
DRY SKIN (1 patients)
DYSPHEMIA (1 patients)
ECZEMA WEEPING (1 patients)
DRY MOUTH (1 patients)
ERYTHEMA (1 patients)
FATIGUE (1 patients)
FEELING ABNORMAL (1 patients)
GENITAL PAIN (1 patients)
HEADACHE (1 patients)
HEARING IMPAIRED (1 patients)
HEART RATE DECREASED (1 patients)
HYPERKERATOSIS (1 patients)
DRY EYE (1 patients)
HYPOREFLEXIA (1 patients)
CONSTIPATION (1 patients)
INJECTION SITE ERYTHEMA (1 patients)
INJECTION SITE IRRITATION (1 patients)
INJECTION SITE SWELLING (1 patients)
INSOMNIA (1 patients)
INTERNATIONAL NORMALISED RATIO ABNORMAL (1 patients)
LEARNING DISORDER (1 patients)
CONDITION AGGRAVATED (1 patients)
LIP SWELLING (1 patients)
LOCALISED INFECTION (1 patients)
LUNG NEOPLASM MALIGNANT (1 patients)
MEMORY IMPAIRMENT (1 patients)
APHASIA (1 patients)
ANXIETY (1 patients)
NAUSEA (1 patients)
NEOPLASM MALIGNANT (1 patients)
PRURITUS (1 patients)
PYREXIA (1 patients)
RASH (1 patients)
AMNESIA (1 patients)
RHINORRHOEA (1 patients)
SOMNOLENCE (1 patients)
SYNCOPE (1 patients)
URTICARIA (1 patients)
ACUTE SINUSITIS (1 patients)
WEIGHT INCREASED (1 patients)
WITHDRAWAL SYNDROME (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AIRBORNE


Issue Description / Topic Timestamp
CONCERN
DRY MOUTH
Took last night have severe dry mouth 2015-11-18 06:01:39
QUESTION
INSOMNIA
I take Amitryptyline and Trazodone. When I use Airborne I cannot get to sleep. 2017-10-07 15:22:45

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about APHASIA and AIRBORNE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AIRBORNE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AIRBORNE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AIRBORNE experts. If you are a healthcare provider experienced in prescribing AIRBORNE, please register here.

Your online appointment book for Dayton Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use